Diagnosing and treating depression in general hospitals

Hospital Medicine

Volumn 65, Issue 2, 2004, Pages 103-107

  Hawley, Chris ^a  

^a QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYTOCHROME P450; ENZYME INHIBITOR; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; NORFLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGITATION; ANORGASMIA; ANXIETY; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DIARRHEA; DIZZINESS; EJACULATION DISORDER; GENERAL HOSPITAL; HEADACHE; HOSPITAL PHYSICIAN; HUMAN; IMPOTENCE; INSOMNIA; LIBIDO DISORDER; MAJOR DEPRESSION; NAUSEA; PSYCHOTHERAPY; REVIEW; SEXUAL DYSFUNCTION; TERMINAL DISEASE; XEROSTOMIA; AUTOMUTILATION; DECISION MAKING; DRUG INTERACTION; HOSPITALIZATION; METHODOLOGY; TERMINALLY ILL PATIENT;

ANTIDEPRESSIVE AGENTS; CHOICE BEHAVIOR; DEPRESSIVE DISORDER; DRUG INTERACTIONS; HOSPITALIZATION; HOSPITALS, GENERAL; HUMANS; PSYCHOTHERAPY; SELF-INJURIOUS BEHAVIOR; TERMINALLY ILL;

EID: 1642486645     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2004.65.2.12069     Document Type: Review

References (13)

1. American Psychiatric Association (2000) Diagnostic Criteria from DSM-IV-TR. American Psychiatric Association, Washington
2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6): 1069-78
3. Bass C, Peveler R, House A (2001) Somatoform disorders: severe psychiatric illnesses neglected by psychiatrists. Br J Psychiatry 179: 11-14
4. British Medical Association and Royal Pharmaceutical Society of Great Britain (2003) British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, London
5. Cozza KL, Armstrong SC, Oesterheld JR (2003) Drug Interaction Principles for Medical Practice. American Psychiatric Publishing, Washington DC
6. Fisch MJ, Loehrer PJ, Kristeller J et al (2003) Fluoxetine vs placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21: 1937-43
7. Joffe R, Sokolov S, Streiner D (1996) Antidepressant treatment of depression: a metaanalysis. Can J Psychiatry 41: 613-16
8. Keller MB, Lavori PW, Mueller TI et al (1992) Time to recovery, chronicity, and levels of psychpathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 49: 809-16
9. Montejo AL, Llorca G, Izqueierdo JA et al (2001) Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 62(3): 10-21
10. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S (2003) Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 289(1): 56-64
11. Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA (2002) Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 181: 208-13
12. Thase ME, Entsuah AR, Rudolph RL (2001) Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 170: 234-41
13. Waugh J, Goa KL (2003) Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs 17(5): 343-62